Recent Advances in Pharmacological Treatments of Adult Dermatomyositis.
Chen KL, Zeidi M, Werth VP.
Curr Rheumatol Rep. 2019 Aug 31;21(10):53. doi: 10.1007/s11926-019-0850-9.
PMID:31473845
Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome.
Cassius C, Le Buanec H, Bouaziz JD, Amode R.
J Immunol Res. 2019 Jan 14;2019:9141420. doi: 10.1155/2019/9141420. eCollection 2019.
PMID:30766892
Calcinosis in dermatomyositis.
Davuluri S, Chung L, Lood C.
Curr Opin Rheumatol. 2024 Nov 1;36(6):453-458. doi: 10.1097/BOR.0000000000001036. Epub 2024 Aug 9.
PMID:39120537
Polymyositis and dermatomyositis (first of two parts).
Bohan A, Peter JB.
N Engl J Med. 1975 Feb 13;292(7):344-7. doi: 10.1056/NEJM197502132920706.
PMID:1090839
Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis.
Best M, Molinari N, Chasset F, Vincent T, Cordel N, Bessis D.
Acta Derm Venereol. 2019 Mar 1;99(3):256-262. doi: 10.2340/00015555-3091.
PMID:30460368
Macrophage activation syndrome in adult dermatomyositis: a case-based review.
Kishida D, Sakaguchi N, Ueno KI, Ushiyama S, Ichikawa T, Yoshinaga T, Shimojima Y, Sekijima Y.